Diet-derived nutrients modulate the effects of amylin on c-Fos expression in the area postrema and on food intake.
The pancreatic hormone amylin decreases food intake via activation of area postrema (AP) neurons. We investigated whether amylin's potency to reduce food intake and to induce c-Fos expression in the AP/nucleus of the solitary tract region is affected by the feeding conditions and specifically by the macronutrient composition of the diet. Whereas a low dose of amylin (5 microg/kg s.c.) induced very little c-Fos expression in ad libitum chow fed rats, it caused a strong c-Fos expression in 24-hour food-deprived rats and in rats that received a nutrient-deficient non-caloric mash (NCM; vanilla-flavoured cellulose) 24 h before injection. To reveal the contribution of single nutrients to the low c-Fos expression after chow feeding, amylin-induced c-Fos was analyzed after feeding NCM that was selectively supplemented with glucose, fat (lard), or protein (casein), matching the intake of these nutrients of chow-fed rats. While the rats fed NCM supplemented with glucose or fat displayed an equally strong amylin-induced activation as fasted rats or rats fed plain NCM, a significantly lower c-Fos expression was observed in rats fed a protein-supplemented NCM or a NCM containing all three nutrients. In line with this lower activation, the same dose of amylin failed to reduce food intake in NCM/protein-fed rats, while amylin caused a reduction in feeding when animals received NCM, NCM/glucose, or NCM/fat. Interestingly, amylin effectively reduced food intake in ad libitum chow fed rats despite the low level of amylin-induced c-Fos expression in the AP under these conditions. We conclude that the anorectic potential of amylin may be attenuated by diet-derived proteins, whereas this effect appears to be overridden when the amount of carbohydrates/fat is high relative to the protein content, such as, e.g., in standard chow.
Michel
Signe
S
Institute of Veterinary Physiology, University of Zürich, Zürich, Switzerland.
Becskei
Csilla
C
Erguven
Elif
E
Lutz
Thomas A
TA
Riediger
Thomas
T
D000682:Amyloid / Q000378:metabolism* / Q000494:pharmacology; D000821:Animal Feed; D000818:Animals; D000897:Anti-Ulcer Agents / Q000378:metabolism* / Q000494:pharmacology; D001066:Appetite / Q000187:drug effects / Q000502:physiology; D031608:Area Postrema / Q000187:drug effects / Q000502:physiology*; D001786:Blood Glucose; D004040:Dietary Carbohydrates / Q000494:pharmacology; D004041:Dietary Fats / Q000494:pharmacology; D004044:Dietary Proteins / Q000494:pharmacology; D004435:Eating / Q000187:drug effects / Q000502:physiology*; D005508:Food Deprivation / Q000502:physiology; D058228:Islet Amyloid Polypeptide; D008297:Male; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar
D000682:Amyloid; D000897:Anti-Ulcer Agents; D001786:Blood Glucose; D004040:Dietary Carbohydrates; D004041:Dietary Fats; D004044:Dietary Proteins; D058228:Islet Amyloid Polypeptide; D016760:Proto-Oncogene Proteins c-fos